| Philipp Lorenz Hannan, MD | |
|
3950 S Country Club Rd, Tucson, AZ 85714-2099 | |
| (520) 626-5582 | |
| Not Available |
| Full Name | Philipp Lorenz Hannan |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 3950 S Country Club Rd, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013365675 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | R75732 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner-university Medical Center South Campus | Tucson, AZ | Hospital |
| Banner - University Medical Center Tucson Campus | Tucson, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner -- University Medical Group | 7719899871 | 819 |
News Archive
Avocados have been hailed as a wonder fruit packed with nutritional values and something diet experts and customers swear by.
Reporting for KHN, in collaboration with Politico, Bara Vaida writes: "Lobbyists for doctors, hospitals and drug companies are urging lawmakers to derail a planned government panel that health industry officials fear will sharply curb Medicare spending - a critical revenue source for them".
Cancer experts from around the world are converging in Denver on Thursday and Friday to analyze the success of cutting-edge radiation therapies, and to determine how one promising treatment option could be delivered for the first time to cancer patients in the United States.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP) to collaborate on the conduct of a randomized Phase 2 trial of ZYBRESTAT in combination with bevacizumab in patients with relapsed ovarian cancer.
› Verified 2 days ago
| Entity Name | Banner -- University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508809427 PECOS PAC ID: 7719899871 Enrollment ID: O20031105000694 |
News Archive
Avocados have been hailed as a wonder fruit packed with nutritional values and something diet experts and customers swear by.
Reporting for KHN, in collaboration with Politico, Bara Vaida writes: "Lobbyists for doctors, hospitals and drug companies are urging lawmakers to derail a planned government panel that health industry officials fear will sharply curb Medicare spending - a critical revenue source for them".
Cancer experts from around the world are converging in Denver on Thursday and Friday to analyze the success of cutting-edge radiation therapies, and to determine how one promising treatment option could be delivered for the first time to cancer patients in the United States.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP) to collaborate on the conduct of a randomized Phase 2 trial of ZYBRESTAT in combination with bevacizumab in patients with relapsed ovarian cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philipp Lorenz Hannan, MD 3950 S Country Club Rd, Tucson, AZ 85714-2099 Ph: (520) 626-5582 | Philipp Lorenz Hannan, MD 3950 S Country Club Rd, Tucson, AZ 85714-2099 Ph: (520) 626-5582 |
News Archive
Avocados have been hailed as a wonder fruit packed with nutritional values and something diet experts and customers swear by.
Reporting for KHN, in collaboration with Politico, Bara Vaida writes: "Lobbyists for doctors, hospitals and drug companies are urging lawmakers to derail a planned government panel that health industry officials fear will sharply curb Medicare spending - a critical revenue source for them".
Cancer experts from around the world are converging in Denver on Thursday and Friday to analyze the success of cutting-edge radiation therapies, and to determine how one promising treatment option could be delivered for the first time to cancer patients in the United States.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP) to collaborate on the conduct of a randomized Phase 2 trial of ZYBRESTAT in combination with bevacizumab in patients with relapsed ovarian cancer.
› Verified 2 days ago
Martin Demant, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 N Campbell Ave, Tucson, AZ 85724 Phone: 520-626-6507 Fax: 520-626-5675 | |
John Guisto, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1501 N Campbell Ave, Tucson, AZ 85724 Phone: 520-874-3500 | |
Dr. Christopher Scott Florence, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5301 E Grant Road, Tucson Medical Center Emergency Department, Tucson, AZ 85712 Phone: 520-324-1922 Fax: 520-324-1088 | |
Dr. Jose Carbajal, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 N Wilmot Rd, Tucson, AZ 85711 Phone: 520-873-5429 | |
Dr. Ajit Itty, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1609 N Warren Ave Rm 118, Tucson, AZ 85724 Phone: 520-626-6312 | |
James Daehyun Kim, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1501 N Campbell Ave, Tucson, AZ 85724 Phone: 520-626-7233 |